GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stem Holdings Inc (OTCPK:STMH) » Definitions » Asset Turnover

Stem Holdings (Stem Holdings) Asset Turnover : -0.60 (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Stem Holdings Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Stem Holdings's Revenue for the three months ended in Sep. 2023 was $-11.78 Mil. Stem Holdings's Total Assets for the quarter that ended in Sep. 2023 was $19.52 Mil. Therefore, Stem Holdings's Asset Turnover for the quarter that ended in Sep. 2023 was -0.60.

Asset Turnover is linked to ROE % through Du Pont Formula. Stem Holdings's annualized ROE % for the quarter that ended in Sep. 2023 was -1,160.46%. It is also linked to ROA % through Du Pont Formula. Stem Holdings's annualized ROA % for the quarter that ended in Sep. 2023 was -237.94%.


Stem Holdings Asset Turnover Historical Data

The historical data trend for Stem Holdings's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stem Holdings Asset Turnover Chart

Stem Holdings Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Asset Turnover
Get a 7-Day Free Trial 0.11 0.37 0.41 - -

Stem Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.34 0.14 0.14 0.15 -0.60

Competitive Comparison of Stem Holdings's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Stem Holdings's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stem Holdings's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stem Holdings's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Stem Holdings's Asset Turnover falls into.



Stem Holdings Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Stem Holdings's Asset Turnover for the fiscal year that ended in Sep. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Sep. 2023 )/( (Total Assets (A: Sep. 2022 )+Total Assets (A: Sep. 2023 ))/ count )
=0/( (30.981+13.347)/ 2 )
=0/22.164
=0.00

Stem Holdings's Asset Turnover for the quarter that ended in Sep. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Sep. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=-11.783/( (25.684+13.347)/ 2 )
=-11.783/19.5155
=-0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Stem Holdings  (OTCPK:STMH) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Stem Holdings's annulized ROE % for the quarter that ended in Sep. 2023 is

ROE %**(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-46.436/4.0015
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-46.436 / -47.132)*(-47.132 / 19.5155)*(19.5155/ 4.0015)
=Net Margin %*Asset Turnover*Equity Multiplier
=98.52 %*-2.4151*4.877
=ROA %*Equity Multiplier
=-237.94 %*4.877
=-1,160.46 %

Note: The Net Income data used here is four times the quarterly (Sep. 2023) net income data. The Revenue data used here is four times the quarterly (Sep. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Stem Holdings's annulized ROA % for the quarter that ended in Sep. 2023 is

ROA %(Q: Sep. 2023 )
=Net Income/Total Assets
=-46.436/19.5155
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-46.436 / -47.132)*(-47.132 / 19.5155)
=Net Margin %*Asset Turnover
=98.52 %*-2.4151
=-237.94 %

Note: The Net Income data used here is four times the quarterly (Sep. 2023) net income data. The Revenue data used here is four times the quarterly (Sep. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Stem Holdings Asset Turnover Related Terms

Thank you for viewing the detailed overview of Stem Holdings's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Stem Holdings (Stem Holdings) Business Description

Traded in Other Exchanges
Address
2201 NW Corporate Boulevard, Suite 205, Boca Raton, FL, USA, 33431
Stem Holdings Inc is involved in a cannabis business. The company is engaged in the manufacture, possession, sale, distribution, and branding of cannabis and its related products. Its brand includes TJ's Gardens; Yerba Buena; Cannavore; Dose-ology and Travis X James.
Executives
Matthew Cohen director, officer: CEO & CFO 1702 COSTA DEL SOL, BOCA RATON FL 33432
Brian John Hayek director 7012 GIRARD ST, MCLEAN VA 22101
Diener Robert Louis Benjamin director 41ULUA PLACE, HAIKU HI 96708
Dennis Suskind director ONE NORTH END AVENUE, WORLD FINANCIAL CENTER, NEW YORK NY 10282
Rajiv Raj director 438B WOBURN AVE, TORONTO A6 M5M1L7
Jessica Michelle Feingold director 3730 W. 24TH AVE, DENVER CO 80211
Lindy L Sinder director 408 BARGARA LANE, BRYN MAWR PA 19010
Garrett Martin Bender director 506 ANDREWS AVENUE, DELRAY BEACH FL 33483
Adam Berk director, officer: President 9370 GRAND ESTATES WAY, BOCA RATON FL 33496
Steven Shelly Hubbard director, officer: CFO 3496 FARIVIEW WAY, WEST LINN OR 97068